S. Piepenbrock (Hannover, Germany), K. Falke (Berlin, Germany)
Improved effect in vivo of a lung surfactant extract by taking time-dependent aqueous swelling behaviour into account
M. Larsson, J. Haitsma, T. Nylander, K. Larsson, B. Lachmann, P. Wollmer (Lund, Sweden; Rotterdam, The Netherlands)
|  |
Therapeutic lavage with rSP-C surfactant restores oxygenation and improves histological outcome in a rat lung lavage model of acute lung injury
L. Wollin, R. Beume, D. Haefner (Konstanz, Germany)
| |
Exogenous surfactant administration in patients at high risk to develop ARDS after multiple trauma
K. Raymondos, J. Braun, M. Martin, T. Schmudlach, M. Brandes, D. Korth, B. Hillmer, W. Bernhard, H. C. Pape, S. Piepenbrock (Hannover, Lubeck, Germany)
| |
When to start surfactant therapy (ST-therapy) of acute lung injury?
O. A. Rosenberg, A. E. Bautin, V. V. Osovskich, E. K. Tcybulkin, S. V. Gavrilin, V. V. Lichvancev, V. V. Erochin, I. A. Kozlov, A. A. Seiliev, V. A. Volchkov, D. A. Granov (Saint-Petersburg, Moscow, Russia)
| |
The outcome of ARDS in children with a PaO2/FiO2 ratio <65 is not improved by either surfactant or rescue therapies (nitric oxide, high frequency ventilation, ECMO)
J. C. Möller, M. Kohl, P. Schmidt, H. Schuhmacher, The ARDS/Surfactant-Study-Group (Lübeck, Germany)
| |
The relation of interleukin-1β (Il-1β) and surfactant parameters in human premature neonates
L. J. Zimmermann, D. J. Janssen, J. E. H. Bunt, S. R. Tati, D. J. Wattimena, W. A. Dik, M. A. Versnel, V. P. Carnielli (Rotterdam, The Netherlands; Padova, Italy)
| |